Skip to main content
Top
Literature
1.
go back to reference Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301–5.CrossRefPubMedPubMedCentral Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29:301–5.CrossRefPubMedPubMedCentral
2.
go back to reference Koike R, Kubota T, Hara Y, Ito S, Suzuki K, Yanagisawa K, et al. A case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin). Mod Rheumatol. 2007;17:496–9.CrossRefPubMed Koike R, Kubota T, Hara Y, Ito S, Suzuki K, Yanagisawa K, et al. A case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin). Mod Rheumatol. 2007;17:496–9.CrossRefPubMed
3.
go back to reference Chang Z, Spong CY, Jesus AA, Davis MA, Plass N, Stone DL, et al. Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes. Arthritis Rheumatol. 2014;11:3227–32.CrossRef Chang Z, Spong CY, Jesus AA, Davis MA, Plass N, Stone DL, et al. Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes. Arthritis Rheumatol. 2014;11:3227–32.CrossRef
4.
go back to reference Levy RA, de Jesus GR, de Jesus NR, Klumb EM. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Autoimmun Rev. 2016;15:955–63.CrossRefPubMed Levy RA, de Jesus GR, de Jesus NR, Klumb EM. Critical review of the current recommendations for the treatment of systemic inflammatory rheumatic diseases during pregnancy and lactation. Autoimmun Rev. 2016;15:955–63.CrossRefPubMed
5.
go back to reference Youngstein T, Lane T, Rowczenio D, Ozdogan H, Ugurlu S, Hoffmann P, et al. Anti-interleukin-1 therapies and pregnancy outcome: an international cohort. Ann Rheum Dis. 2015;74(suppl 2):860. Youngstein T, Lane T, Rowczenio D, Ozdogan H, Ugurlu S, Hoffmann P, et al. Anti-interleukin-1 therapies and pregnancy outcome: an international cohort. Ann Rheum Dis. 2015;74(suppl 2):860.
6.
go back to reference D’Ippolito S, Tersigni C, Marana R, Di Nicuolo F, Gaglione R, Rossi ED, et al. Inflammosome in the human endometrium: further step in the evaluation of the “maternal side”. Fertil Steril. 2016;105:111–8. D’Ippolito S, Tersigni C, Marana R, Di Nicuolo F, Gaglione R, Rossi ED, et al. Inflammosome in the human endometrium: further step in the evaluation of the “maternal side”. Fertil Steril. 2016;105:111–8.
7.
go back to reference Hashira S, Okitsu-Negishi S, Yoshino K. Placental transfer of IgG subclasses in a Japanese population. Pediatr Int. 2000;42:337–42.CrossRefPubMed Hashira S, Okitsu-Negishi S, Yoshino K. Placental transfer of IgG subclasses in a Japanese population. Pediatr Int. 2000;42:337–42.CrossRefPubMed
8.
go back to reference Paccaud Y, Berthet G, Von Scheven-Gete A, Vaudaux B, Mivelaz Y, Hofer M, et al. Neonatal treatment of CINCA syndrome. Pediatr Rheumatol Online J. 2014;12:52.CrossRefPubMedPubMedCentral Paccaud Y, Berthet G, Von Scheven-Gete A, Vaudaux B, Mivelaz Y, Hofer M, et al. Neonatal treatment of CINCA syndrome. Pediatr Rheumatol Online J. 2014;12:52.CrossRefPubMedPubMedCentral
Metadata
Title
Placental Transfer of Canakinumab in a Patient with Muckle-Wells Syndrome
Authors
Makiko Egawa
Kohsuke Imai
Masaaki Mori
Naoyuki Miyasaka
Tetsuo Kubota
Publication date
01-05-2017
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2017
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-017-0389-3

Other articles of this Issue 4/2017

Journal of Clinical Immunology 4/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.